GlaxoSmithKline (Spain)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

    Cell Chemical Biology, Vol. 28, Núm. 5, pp. 711-721.e8